Abstract:
Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Abstract:
Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
Abstract:
Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
Abstract:
Imidazoquinoline compounds with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
Abstract:
The present disclosure provides an oil-resistant adhesive comprising a crosslinked copolymer of (meth)acrylic ester monomers, methyl (meth)acrylate monomers, vinyl ester monomers, and a functional monomer selected from one of (meth)acrylic acid, a (meth)acrylamide or a hydroxyalkyl (meth)acrylate monomers.
Abstract:
Described herein is a mixture comprising: (a) a non-self-crosslinking polymer; and (b) a modifying compound comprising: (i) a first functional group capable of reacting with the reaction sites of the non-self-crosslinking polymer; and (ii) a second functional group capable of crosslinking with a curing agent, wherein the first functional group is different than the second functional group. Also, described are curable polymeric compositions, and methods of making cured polymeric compositions.
Abstract:
Described herein is a composition comprising at least one of: X—R—(Z)n wherein X is selected from: an aziridine amide, an aziridine urea, an isocyanate, an alcohol, an amine, an epoxy, or a sulfhydryl, R is a multifunctional organic group, and Z is selected from —N3 or —C≡C—R′, wherein R′ is a hydrogen or a monofunctional organic group and n is from one to about 10. Also, described are mixtures, curable polymeric compositions, and methods of making cured polymeric compositions.
Abstract:
Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N-1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing (or inhibiting) cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.
Abstract:
The present disclosure provides an oil-resistant adhesive comprising a crosslinked copolymer of (meth)acrylic ester monomers, methyl (meth)acrylate monomers, vinyl ester monomers, and a functional monomer selected from one of (meth)acrylic acid, a (meth)acrylamide or a hydroxyalkyl (meth)acrylate monomers.